Key facts
- Eclipse Ingredients’s last known valuation is $8.0M (Feb 2025).
- It has raised $2.6M; the latest was Early Stage VC ($2.6M) in Feb 2025.
- Notable investors include AgFunder, CSIRO.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Eclipse Ingredients
- ·The full record, as it builds
Funding rounds
No funding rounds for Eclipse Ingredients are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Eclipse Ingredients
Developer of precision-fermented nutrition ingredients intended for use in health and wellbeing applications across life stages. The company uses precision fermentation processes to produce pure functional proteins and related compounds, beginning with human lactoferrin, and is structured as a scalable ingredient and technology platform that combines conscious production, efficiency-focused process design, and partnership-oriented development, enabling consumer health, nutrition, and wellness product markets to access consistent, sustainable.
- Sector
- Healthcare
- HQ
- Brisbane, Australia
- Founded
- 2024
- Employees
- 2
- Website
- eclipseingredients.com/
- Ownership
- Privately Held (backing)
Eclipse Ingredients doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Eclipse Ingredients shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Eclipse Ingredients in its N-PORT filings yet. We sweep new filings monthly.